Cancer Family
Peritoneal and Retroperitoneal Neoplasm
CI-CAN-00000045Explore in graph →
Non-malignant207 active trials6 approved drugs6 evidence items
- NCIt
- C7337
Loading cancer entity…
Cancer Family
CI-CAN-00000045Explore in graph →
Clinical trials
887 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05080946 | Using Aspirin to Improve Immunological Features of Ovarian Tumors | suspended | Early Phase 1 | 100 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT05337735 | A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers | suspended | Phase 2 | 140 | M.D. Anderson Cancer CenterOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT03875144 | Treatment of Malignant Peritoneal Mesothelioma (MESOTIP)(MESOTIP) | suspended | Phase 2 | 66 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT00753480 | A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | suspended | Phase 1 | 56 | Genentech, Inc.INDUSTRY | 1 | Nov 7, 2008 | clinicaltrials |
Data updated 14 days agoSource updated Sep 15, 2026source: clinicaltrials